Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 5 | 2024 | 2886 | 1.090 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 1615 | 0.790 |
Why?
|
| Transcriptome | 2 | 2024 | 580 | 0.710 |
Why?
|
| Haptoglobins | 1 | 2017 | 9 | 0.630 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 144 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2024 | 2269 | 0.570 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 696 | 0.550 |
Why?
|
| Quantitative Trait Loci | 2 | 2023 | 576 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2024 | 2354 | 0.270 |
Why?
|
| Receptors, Estrogen | 2 | 2024 | 384 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 108 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1197 | 0.200 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 30 | 0.200 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 158 | 0.190 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 365 | 0.190 |
Why?
|
| Aspirin | 1 | 2021 | 156 | 0.180 |
Why?
|
| Female | 9 | 2024 | 44489 | 0.180 |
Why?
|
| Hypertension, Renal | 1 | 2020 | 40 | 0.180 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 329 | 0.170 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 139 | 0.170 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 329 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 345 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 645 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Humans | 12 | 2024 | 86526 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 878 | 0.140 |
Why?
|
| Sleep | 1 | 2020 | 444 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 154 | 0.130 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 521 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 350 | 0.130 |
Why?
|
| Risk Factors | 2 | 2022 | 5413 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1716 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2021 | 730 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2020 | 1143 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 711 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 388 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 1075 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 1051 | 0.080 |
Why?
|
| Estrogens | 1 | 2024 | 200 | 0.060 |
Why?
|
| Australia | 1 | 2023 | 99 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 299 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 141 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 93 | 0.050 |
Why?
|
| Introns | 1 | 2021 | 289 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 83 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 215 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2020 | 256 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2023 | 535 | 0.040 |
Why?
|
| Adult | 3 | 2023 | 25627 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 770 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 8464 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 839 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1239 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 124 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 133 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2016 | 439 | 0.030 |
Why?
|
| Male | 3 | 2023 | 40944 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 502 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 18398 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 311 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3673 | 0.030 |
Why?
|
| Smoking | 1 | 2016 | 606 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 625 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 25013 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 4208 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 5209 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5971 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8976 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 7981 | 0.020 |
Why?
|